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ROLE OF PHYTOESTROGENS ON EXPRESSION OF 
OXYTOCIN AND OXYTOCIN RECEPTORS AND 
RESULTING BEHAVIORAL CHANGES IN HUMANS 
MATTHEW J. PARKER 
 
ABSTRACT 
 
Soy based products are growing in popularity in food supplementation, and a larger 
population of the world is consuming soy on a regular basis.  Soy contains 
phytoestrogens, plant based mimics of the hormone estrogen.  Estrogen has many 
functions in humans, but one relatively unexplored function is its ability to regulate the 
levels of the hormone oxytocin (OT) and its receptor (OTR) in the brain.  OT is a 
hormone traditionally known for its role in birth, but recently has been as a key regulator 
in many different behaviors.  These behaviors that OT may affect include increased 
maternal behaviors, increased sexual behaviors, increased social interactions, increased 
trust, decreased anxiety, and increased potential for pair bonding.  Key phytoestrogens 
found in soy are of the isoflavone family, and genistein and diadzein are the main two 
isoflavones that have been shown to exert physiologic effects when ingested by binding 
to estrogen receptors in the brain.  The isoflavones can be estrogen agonists or estrogen 
antagonists, based on the preexisting, endogenous levels of estrogen in the individual.  
For men and postmenopausal women, it is believed that ingesting soy can cause an 
increase in production of OT and OTR, resulting in an increased in OT driven behaviors.  
For premenopausal women, there is a high endogenous level of estrogen present, so the 
ingested soy can cause a decrease in production of OT and OTR in the brain, resulting in 
v 
a decrease in OT driven behaviors.  While there is strong evidence to suggest that this 
may in fact occur in humans, more human based studies, rather than animal models, must 
be conducted to further verify and validate this hypothesis.  An important area yet 
unexplored is the onset and duration of these OT driven behaviors.  It is unclear if these 
are transient, or more long lasting effects, and future studies must be done to answer this 
question.  This area of research is certainly more relevant as soy based diets are becoming 
more common; moving forward additional research is needed to determine the extent of 
oxytocin’s ability to alter behaviors in individuals in a significant way.  
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INTRODUCTION 
Phytoestrogens  
 Phytoestrogens are plant derived estrogen mimics that can enter the human body 
through ingestion of phytoestrogen rich plants.  They have a similar chemical structure to 
endogenous estrogen, but have a far lower potency (Lephart et al, 2002).  Three main 
types of phytoestrogens exist, and in order of decreasing potency, they are coumestans, 
isoflavones and lignans.  An example of a commonly ingested phytoestrogen is the soy 
bean, with the bean containing isoflavones, while the stalk is rich in coumestans 
(Murkies, Wilcox and Davis, 1998).  The prevalence of soy in human diets is high in 
many Asian cultures, and is on the rise in Western cultures, since it is increasingly being 
added into processed foods and used as a supplemental protein (Patisaul and Jefferson, 
2010). 
There is much debate about the positive and negative effects that phytoestrogens 
have on humans.  While they are cited as having a positive impact on such things as bone 
health, preventing particular cancers, preventing heart disease and acting as a valid 
hormonal replacement for post menopausal women, there is also data showing that it is 
an endocrine disruptor (Patisaul and Jefferson, 2010). As an endocrine disruptor, it is 
capable of inhibiting key endocrine based processes such as proper function of 
hormonally stimulated protein kinases in the brain, interfering with key processes such as 
forming memory through long term potentiation (Patisaul and Jefferson, 2010).  There is 
also the unexplored issue of stimulation of gene transcription that normally results from 
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estrogen stimulation, specifically the upregulation of the oxytocin receptor (OTR) and 
production of oxytocin (OT) in the brain.   
Oxytocin 
 OT is a nine amino acid neuropeptide hormone that is synthesized in the 
paraventricular nucleus (PVN) and the supraoptic nucleus (SON), and can be released to 
have paracrine effects in the brain, or released from the posterior pituitary into the blood 
stream, exhibiting endocrine functions on specific regions of the body (Neumann, 2008).  
The classically documented actions of oxytocin are promoting uterine contraction during 
child birth, acting in a positive feedback loop, resulting in stronger and stronger 
contractions until the child is born.  Its other well-known role is milk letdown in 
breastfeeding mothers, stimulated by the tactile event of suckling, resulting in milk being 
released from the maxillary glands via smooth muscle contraction.  However, recently, 
densities of OTR in the brain have been linked to many behavioral consequences (Young, 
Muns, Wang and Insel, 2003) 
There is significant animal and human evidence for OT increasing levels of trust, 
regulating sexual behavior, facilitating social interactions such as pair bonding and better 
perception of social cues, and having anxiolytic effects (MacDonald and MacDonald, 
2010).  There is even evidence that, due to its association and stimulation of the 
mesolimbic dopaminergic reward pathway, it may have an association with addiction and 
pleasure/reward circuitry  (Baskerville and Douglas, 2010).   This is relevant to this study 
because the two main estrogen receptors (ER) in the brain, ERα and ERβ, have a 
significant affinity for certain phytoestrogens, which may act to stimulate the effector 
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functions of these two receptors, which include upregulation of OT production and OTR 
production, respectively (See Figure 1) (Rissman, 2008).   It has been observed in pigs 
that feeding them a phytoestrogen rich diet actually doubled the production of circulating 
OT, which while not a direct measurement of the brain concentrations of OT, is 
indicative that phytoestrogens have a potent potential to influence OT levels (Norrby et 
al., 2011). Therefore it is possible that phytoestrogens could have a significant impact on 
these OT mediated behavioral responses. 
 
Young, we asked which ER induced oxytocin and its receptor. Using
gonadectomised WT and ERaKO mice of both sexes, we treated
some animals with E2 and others with vehicle. Regardless of sex,
E2 induced oxytocin binding (a reflection of receptor abundance)
throughout the hypothalamus. This response was blocked in ERaKO
mice (48). In another study we used ERbKO and WT female mice to
examine oxytocin mRNA in the PVN. In this study, hormone priming
was conducted, followed by in situ hybridisation. Oxytocin mRNA
was elevated in the WT PVN after hormone treatment, but not in
the ERbKO brain (47). As confirmation of the early data on the oxy-
tocin receptor, in both the WT and ERbKO female mice, receptor
message in the hypothalamus and amygdala was induced with hor-
mone priming. This is an example of both an autonomous and a
synergistic relationship, as ERb increases the amount of oxytocin
peptide produced, and ERa increases expression of its receptor
(Fig. 2).
A different type of ER synergy has been noted in the anteroven-
tral periventricular nucleus (AVPV), a subregion of the medial preop-
tic area. The cells in this area are sexually dimorphic, with females
having more than males (49). Often the population of cells is
revealed with immunocytochemistry for tyrosine hydroxylase (TH),
and the TH-positive labelled neurones in the AVPV are known to
produce dopamine. Not only is this a structural sex difference, but it
is also functional as the dopamine-containing neurones project to
nearby gonadotrophin-releasing hormone (GnRH)-containing cells,
and are thought to be involved in the ovulatory release of GnRH
from these cells (50). Studies with the ERaKO mouse showed that
WT females had more cells positive for TH in the AVPV than WT
males, ERaKO males or ERaKO females (51). At the time this obser-
vation was made, ERb had just been discovered, and thus little was
made of the fact that ERaKO males and females had AVPV cell
numbers that were not completely ‘female-like’ and instead were
intermediate between WT males and females. A few years ago
we decided to revisit this question of ER regulation and labelled
neurones in the AVPV with TH in brains of mice from both ERKO
strains and double-KO individuals (52). Only in WT individuals was
the sex difference in the AVPV present. All the KO mice, both males
and females, had ‘female-like’ high numbers of dopaminergic
neurones in the AVPV. These data showed that the two ERs work in
concert in this region to elaborate the sex difference in cell numbers.
We presumed that the actions occurred during development as this
sex difference is organised prior to postnatal day 7 in rats (49, 53).
Interestingly, ERaKO females lack positive and negative feedback to
E2 (8, 54), and ERbKO mice have normal negative feedback but
ovulate a reduced number of ova as compared with WT females
(12, 55). Afferents from GnRH neurones are specifically associated
with ERa-containing neurones in the AVPV, suggesting that the ERa
in the AVPV is directly involved in GnRH regulation (54).
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Fig. 1. This cartoon illustrates the antagonistic relationship between the two oestrogen receptors (ERs). The white diamond represents ERb, the black diamond
represents ERa, and the grey triangle is oestradiol activating the receptors. An ERb-specific agonist is represented by the off-grey pentagon. (A) The example
shows the impact of excess oestradiol on the two ERs and the resulting behaviour. (B) The relationship is shown when an ERb agonist is used.
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Fig. 2. This cartoon figure illustrates the synergistic relationship between
the two oestrogen receptors (ERs). The white diamond represents ERb, the
black diamond represents ERa, and the grey triangle is oestradiol activating
the receptors. Below each receptor is the oxytocin gene that it affects.
Oestrogen receptors a and b in behavioural neuroendocrinology 875
ª 2008 The Author. Journal Compilation ª 2008 Blackwell Publishing Ltd, Journal of Neuroendocrinology, 20, 873–879
 
Figure 1. Estrogen Receptors Influence on Oxytocin. Two types f estrogen r ceptors 
(ERα and ERβ) l cated i  the brain respond to estrogen in varying ways that 
synergistically affect a response to oxytocin.  The grey triangle represents estrogen 
binding to and stimulating the ER, which then stimulates gene transcription of either 
expression of the Oxytocin peptide (ERβ) or the oxytocin receptor (ERα) (Figure taken 
from Rissman, 2008). 
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Specific Aims/Objectives 
 Previous studies have shown conflicting results of whether phytoestrogens have 
an estrogenic (estrogen mimicking) or antiestrogenic (estrogen antagonizing) effect on 
the body, and whether that is beneficial or not for health.  Varying models and molecules 
makes consolidation of the studies difficult to draw conclusions from.   Almost none of 
these studies have done extensive research on phytoestrogen’s influence on alterations 
that may occur in the brain’s receptor expression density, specifically of the OTR.  There 
also seems to be little concern into how phytoestrogens alter the expression of both brain 
based OT and OTR, and even less interest in the general effects of phytoestrogens in non-
menopausal based models (animal or human). 
 The goal of the present study is to look for the potential affects of phytoestrogens 
on the expression of OT and OTR in the brain of humans, and the behaviors that follow.  
Specifically, 
1. What phytoestrogens are estrogenic and what phytoestrogens are antiestrogenic? 
2. What influence do ingested, estrogenic phytoestrogens have on animals/humans in 
relation to the expression of OTR and OT in the brain? 
3. Are the altered expressions of OTR and OT significant enough to cause measurable 
behavioral changes and if so, what are they? 
The hope is to demonstrate that phytoestrogens do in fact have a significant influence 
on the expression of OTR and OT and that the behaviors that follow are observable.  This 
could illuminate potential harmful effects of phytoestrogen rich diets as well as risks 
involved with hormone replacement therapy. 
5 
Previous Studies 
Significant Phytoestrogens and Food 
In order for the proposed hypothesis to be accurate, particular phytoestrogens 
must be found in common food sources for humans, and must be concentrated enough in 
normal consumption to have a significant biological effect.  In addition the biological 
effect of the phytoestrogen must be estrogenic to result in the proposed behavioral 
changes induced by the OT and OTR upregulation.   
 Phytoestrogens are non-steroid based plant compounds that induce either the 
characteristic actions of steroidal estrogens, referred to as estrogenic activity, or as 
antagonist to estrogenic activity, or antiestrogenic activity.  Divided up into 
isoflavonoids, flavonoids, coumestans, stilbenes and lignans, the category that is of most 
interest to this study are the isoflavones.  (see Figure 2).  Within isoflavones are two 
variations that have been studied in length in regards to their effect on the hormone 
estrogen, or estradiol.  The mechanism through which these isoflavones work is by the 
digestion of the glycosides (from which they are stored in the plants) via the bacteria of 
the intestines.  This yields estrogenic metabolites such as equol, enterolactone and 
enterodiol (Dixon, 2004). 
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Figure 2. Molecular Structures of Isoflavones and Their Metabolites.  The 
biologically inactive isoflavones genistin and diadzin, found in soy products, as well as 
glycitin, are processed within the body and converted to the biologically active forms 
genistein, diadzein and glycitein, respectively.  Diadzein is further converted into the 
biologically active equol.  The structure of β-estradiol is displayed to show the structural 
similarities between the biologically active isoflavones and the endogenous form of 
estrogen in the body (Figure taken from Aehle et al, 2011). 
 
 
 Soybean (Glycine max) is the main dietary source of the isoflavone class of 
phytoestrogens.  Various studies have found that soybeans vary greatly in their 
composition and content of isoflavones, and this variability is due to the variety of soy 
that is grown, as well as the environmental conditions in which they are grown (Wang 
and Murphy, 1994; Caldwell et al., 2005).   The environmental conditions that have been 
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shown to affect the isoflavone content include variations in temperatures, drought, pests, 
and light conditions.  As a result the degree of isoflavone content variation can be as high 
as a three fold difference between two soy crops, cultivated at the same time, but in 
varying geographical locations (Wang and Murphy, 1994). 
 The two major isoflavones in soy, and thus the two major isoflavones of this 
study, are genistein and diadzein.  They are, however, present in soy as β-D- glycosides, 
and are biologically inactive in this form (Setchell, 1998).  After ingestion, the glycoside 
forms of the isoflavones are hydrolyzed by bacterial β-glucosidases in the intestines.  
This hydrolyzation results in the bioactive aglycone forms of genistein and diadzein, 
which can be absorbed by the intestinal tract.  Diadzein and genistein can both be further 
metabolized, diazein into equol and O-demethyangolesin, and genistein to p-ethyl phenol.  
Equol and O-demethyangolesin are also biologically active aglycones, and genistein, 
diadzein, O-demethyangolesin and equol are the major isoflavones found in the blood 
and urine of humans (Setchell, 1998). 
 As mentioned, the concentration of isoflavones in soy varies significantly based 
on its environment, but it is also very dependent of the manner in which the soybeans 
have been processed.  In fact, processing soy via alcohol extraction can dissociate 
isoflavones from soy proteins, which results in a significantly diminished concentration 
of isoflavones within the consumed soy (Bhathena and Velasquez, 2002).  The variations 
in preparation explain the corresponding variation in isoflavone concentration per gram 
of soy protein.  For example, 0.1-5 mg of isoflavones per gram of soy protein is found in 
mature and roasted soybeans, 0.3 mg of isoflavone per gram of soy protein is in green soy 
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beans, and 0,1-2 mg of isoflavone per soy protein is found in tofu and soy milk 
preparations (Bhathena and Valasquez, 2002). 
While there are numerous studies investigating the plasma concentrations of 
isoflavones in humans consuming a soy enriched, or soy poor diet, there have not been 
many studies done on the isoflavone levels in the cerebrospinal fluid, or the degree to 
which the isoflavones may pass through the blood brain barrier in order to have a central 
nervous system effect (Lephart et al., 2000).  It is within the central nervous system, 
specifically the brain, that must be looked at to asses the impact of soy ingestion. 
Neurological Interactions of Phytoestrogens  
For any of these studies to be relevant for the overall aim of this paper, 
isoflavones must be able to pass through the blood brain barrier, from general circulation, 
into the brain.  A study was done where the isoflavones genistein and daidzein were 
injected intraperitoneally into rats, quickly appearing in high levels in the brain tissue of 
the rats.  Like the naturally occurring estrogen, the isoflavones have no trouble entering 
the lipophilic environment of the brain. (Gamache et al., 1996).  Using time resolved 
fluoroimminoassay on lyophilized brain tissue, the relative isoflavone content was 
determined for specific brain regions (Wang et al., 2000).  In one study, the concentration 
of genistein and diadzein in the medial basal hypothalamus was almost eightfold higher 
in the group of rats fed a phytoestrogen rich diet verses those fed a phytoestrogen free 
diet (Lephart et al., 1996).   
Lepthart et al. improved upon the phytoestrogen identification technique and 
confirmed that genistein, diadzein, as well as daidzein’s metabolite equol, are 
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concentrated in the medial basal hypothalamus, as well as finding that the phytoestrogen 
concentrations in the cerebellum were approximately nine-fold higher in the rats fed the 
phytoestrogen rich diet than the rats fed the phytoestrogen free diet (Lepthart et al., 
2000).   In a separate study, the same researchers found that the frontal cortical region of 
the brain had a fifty-fold increased concentration in phytoestrogens for the rats on the 
phytoestrogen rich diet, compared to animals on the phytoestrogen free diet (Lund et al., 
2001).  
An important similarity between all of these brain areas is that they all share a 
high concentration of estrogen receptors (ERs), specifically ERβ.  Once the isoflavones 
have passed through the blood brain barrier, their mechanism of action will then be 
through interaction with the ERs α and β.  Diadzein, genistein and equol have varying 
binding affinities to ERα and ERβ, but the three isoflavones have a preferential binding 
to ERβ (see Table 1A)(Kuiper et al., 1998).  In addition, the relative transactivation was 
measured for diadzein, genistein, and equol (see Table 1B).  The relative transactivation 
is the ability of each of the isoflavones to regulate gene expression of the to ERα and 
ERβ gene.  Genistein had the highest relative transactivation activity for to ERα gene and 
equol had the highest relative transactivation activity for the ERβ gene.  While the 
binding affinity of the isoflavones was not particularly strong, but in a physiologic system 
where endogenous estrogen is present, the isoflavones can compete with estrogen for 
their ER binding.  In addition, the relative transactivation activity for all three key 
isoflavones was fairly close to the transactivation activity of endogenous estrogen, 
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showing that they play a large role in influencing the endogenous estrogen hormonal 
system (Kuiper et al., 1998). 
  
Table 1. Relative Binding Affinity and Relative Transactivation Activity of Estrogen 
and Isoflavones in relation to ERα and ERβ.  (A) Relative binding affinity of each 
isoflavone was calculated as ratio of concentrations of estrogen and isoflavone required 
to reduce the specific radioligand binding by 50% Relative binding affinity value for 
estrogen was arbitrarily set at 100. (B) The relative transactivation activity of each 
isoflavone was calculated as the ratio of luciferase reporter gene induction values of each 
isoflavone, with a concentration of 1000 nm and the luciferase reporter gene induction 
value of 17β-estradiol at 1000 nm. The transactivation activity of estrogen was arbitrarily 
set at 100 (Data taken from Kuiper et al., 1998). 
 
(A)  
Compounds ERα  ERβ 
Estrogen 100.00 100.00 
Genistein 3.10 18.13 
Diadzein .25 .79 
Equol .28 1.87 
 
(B) 
Compounds ERα  ERβ 
Estrogen 100.00 100.00 
Genistein 83.13 84.76 
Diadzein 72.29 80.95 
Equol 80.72 96.19 
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Knowing where the phytoestrogens seem to concentrate in the brain is important, 
and that those areas also have ERs located there provides a strong case for phytoestrogens 
acting through the ERs in the brain.  But since following ingestion of soy results in an 
increase in these isoflavones globally in the brain, it is also important to identify every 
area of the brain that ERα and ERβ have been found (Lund et al., 2001).    In a very 
thorough study using immunohistochemical (IHC) staining, ERα and ERβ were mapped 
out on the mouse brain. ERβ immunoreactivity was found in the olfactory bulb, cerebral 
cortex, preoptic area, amygdala, PVN, thalamus, ventral tegmental area (VTA), 
substantia nigra, dorsal raphe, locus coeruleus, and cerebellum.  ERα and ERβ 
distribution was very similar, except ERα was the predominant receptor type in the 
hippocampus, preoptic area, and the hypothalamus, while it was less prevalent than ERβ 
in the cerebral cortex and the cerebellum (Mitra et al., 2003).   
In the human brain, the ER distributions are less well known and seem to be far 
more complex in their nature.  In an expansive study by Gonzalez done on developing 
and adult human brains, 38 fetal human brains at various ages and 8 adult brains (4 
males, 4 females) of varying ages were sectioned and stained for ERα and ERβ.  ERα in 
prenatal human brains was localized in the developing cortex, but steadily decreased up 
until birth, at which point it began to increase again.  ERβ seemed to appear later in 
prenatal development than ERα, but ERβ continued to increase prior to birth, and 
continue so after birth into adulthood.  It was determined that in adult brains, that both 
ERs were highly concentrated throughout the cortex, as well as in the pyramidal cells of 
the hippocampus, but in both the cortex and the hippocampus, the expression of ERβ was 
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higher than ERα, with a significantly higher concentration of ERs in the cortex for 
women, and no significant sex difference in the hippocampus (Gonzalez et al., 2007).  
From these studies, it is clear that ERs are widely distributed in human brains, but that the 
neuroanatomical differences between mice and humans are significant enough to warrant 
more human studies for a clearer picture of ER distribution in conjunction with 
phytoestrogen concentration. 
Not only do isoflavones bind to ERs in the brain, but their impact on the brain is 
morphological as well.  Studies have looked at how ingestion of a phytoestrogen rich diet 
affects the morphology of certain areas of the brain in perinatal gonadectomized female 
rats.  The sexually dimorphic nucleus in the preoptic area of the hypothalamus (SDN-
POA) is normally between two and five times larger in male rats than female rats, and 
after a genistein rich diet, the SDN-POA volume in the males significantly increased 
(Faber and Hughes Jr., 1991).  Interestingly, in intact females exposed to genistein, there 
was a decrease in SDN-POA, although not statistically significant.  This suggests that 
phytoestrogens have varying effects on SDN-POA volumes, and this variability depends 
on the preexisting hormonal level of endogenous estrogen, i.e. gonadectomized vs. intact 
(Faber and Hughes Jr., 1993). 
  Furthering this study into adulthood, rats were fed a phytoestrogen rich diet for 75 
days, at which point, one half of the male and female rats were taken off the 
phytoestrogen rich diet, while the other half were kept on the same phytoestrogen rich 
diet, remaining on those diets until 120 days old.  Upon reaching 120 days, the animals 
were sacked and brain tissue was collected and SDN-POA size was determined.  The 
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results of this study are shown in Figure 3.  This again shows that in females, a phyto-rich 
diet decreased the size of the SDN-POA, although not significantly, while in males, a 
phyto-rich diet significantly increased the size of the SDN-POA (Lephart et al., 2002).   
In this study, the PVN was analyzed as well, and similar results were found.  The PVN is 
normally larger in females than in males in rats fed a phyto-free diet, but after a phyto-
rich diet, the female PVN experienced significant decrease in volume, while the male 
PVN experienced a significant increase in volume (Lephart et al., 2002).  The volume 
changes that occurred in both sexually dimorphic brain areas can be attributed to 
phytoestrogen mimicking naturally occurring estrogen.  Estrogen is a hormone that can 
stimulate cells with ERs, often resulting in tissue growth, as seen in the males of this 
study, but can also exhibit classical negative feedback mechanisms when the hormonal 
system detects an abnormally high level of estrogen, such as in the females, and result in 
tissue atrophy (Garcia-Segura et al., 1998).   As will be discussed when addressing the 
estrogenic and antiestrogenic capabilities of phytoestrogens, it seems that in the presence 
of high levels of endogenous estrogen, such as in healthy, premenopausal females, 
phytoestrogens act antiestrogenically.  In environments where the endogenous estrogen 
levels are low, such as in healthy males, it seems that phytoestrogens act estrogenically. 
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Figure 3. Volumes of the SDN-POA in Male and Female Rats. The volume in mm3 
x10-3 comparing rats of both genders fed two varying diets.  Both diets were phyto-rich 
for 75 days, then the phyto-free was switched to a diet with no phytoestrogens (shown in 
white) while the phyto-rich continued on the diet high in phytoestrogens.  All rats were 
sacrificed at day 120. The SDN-POA volumes of males fed the phyto-rich diet were 
significantly larger than females fed the phyto-rich diet or males switched to the phyto- 
free diet. The larger SDN-POA volumes of females switched to the phyto-free  diet 
approached significance ( p < 0.07) when compared to the volumes of females fed the 
Phyto- rich diet, but there was no significant difference between their averages (Figure 
from Lephart et al., 2002) 
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Estrogenic and Antiestrogenic Activity 
 Phytoestrogens, as the name suggests, are estrogen mimics, so one would thing 
that they must have the same estrogenic effects as estrogen.  However, due to the various 
sensitivities of different tissues with the ER’s, as well as the relative level of endogenous 
estrogen already existing in the body plays a large role in determining the effect of the 
exogenous phytoestrogens on the estrogen hormonal system. 
 Hwang looked at various isoflavones in several in vitro systems and evaluated the 
estrogenic and antiestrogenic properties of these isoflavones.  As seen in Table 2, the 
relative transcriptional activity of genistein, diadzein, and equol were all over 80% the 
activity of estrogen, suggesting that in the absence of endogenous estrogen, these 
isoflavones act estrogenically (Hwang et al, 2006).  The concentration at which these 
isoflavones acted estrogenically was 10-7 M, which is a concentration of isoflavones that 
can be reached following consumption of a meal rich in soy protein (Lampe et al., 1998).  
In a similar scenario, where the isoflavones were introduced in the presence of an 
estrogen concentration of 10-11 M, a concentration consistent with that of postmenopausal 
women, the isoflavones all acted as an estrogen agonist.  In contrast to this, the 
transactivation activity in the presence of a premenopausal concentration of estrogen, 
around 10-9 M, was significantly inhibited by the addition of the isoflavones.  Diadzein 
and equol were unique in this experiment in that they tended to lose their inhibitory effect 
in higher concentrations, becoming estrogenic again at around 10-6 M, a concentration 
that would be possible from consumption of soy, although it would have to be a very 
large amount (Hwang et al, 2006).  
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From this study it can be observed that there is a dual behavior of phytoestrogens 
that is dependent on the coexisting estrogen concentrations found in the environment to 
which the phytoestrogens are introduced.  The specific isoflavones act as 
antiestrogenically, antagonizing the estrogenic actions, at physiologic levels of estrogen, 
ones that would occur premenopausally.    This inhibitory effect is likely due to the 
competitive reaction of the ER between the isoflavone and the endogenous estrogen, as 
well as the lower potency the compound intrinsically has, and this inhibitory effect was 
more significant with the ERβ than with ERα (Hwang et al, 2006).  In contrast to this, in 
the presence of lower endogenous estrogen levels, levels similar to postmenopausal 
women, the isoflavones had overall estrogenic effects.  A concentration that would be 
obtainable from soy consumption was potent enough to be significantly agonistic to 
estrogenic activities (Hwang et al, 2006).   
 In the study, cells, consisting of human breast cancer cells, human embryonic 
kidney H293 cells, mouse osteoblast and monocytic cells were evaluated.  While this 
study was very enlightening in how isoflavones behave under premenopausal and 
postmenopausal estrogen conditions, a point that is essential to this study, the cell types 
were not in the area of concern for this study, the brain.  While it could be assumed that 
the brain tissue behaves in a similar way to other tissues in the body, since the ER’s are 
conserved across tissue type, and it is through the ER’s that the isoflavones exert their 
effects, a more specific, human brain cell study would need to be done in order to be fully 
certain of the estrogenic and antiestrogenic effects. 
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Oxytocin and OTR in the Brain 
OT is a nine amino acid peptide that is produced in magnocellular neurosecretory 
neurons found in the PVN and SON of the hypothalamus.   Upon stimulation via 
electrical activity, OT is released from the PVN and SON through OT neurons, either to 
the posterior pituitary gland, or locally into various regions of the brain.  The OT released 
into the posterior pituitary gland is released into the bloodstream and acts peripherally to 
do two well-known functions; that of aiding in parturition through uterine contraction, 
and milk letdown during breast feeding through contraction of the mammary glands 
(Gimpl and Fahrenholz, 2001).  There exists plasticity to OT and OTR in this system, for 
example around the time of pregnancy: SON architecture is substantially remodeled in 
lactation, changing the synaptic morphology, as well as a hypertrophy of OT neurons that 
may an adaptive response to the increased need for OT in milk let down.  There also 
seems to be a decreased responsiveness of OTR to stimuli late in pregnancy that may 
allow for pituitary stores of OT to accumulate, in anticipation of the increased need for 
OT during parturition, as well as to reduce the potential for a premature birth (Theodosis 
et al 2006). 
Until recently, there was no relatively clear view into the concentration and 
distribution of the OTR in the human brain. Dozens of autoradiographic studies have 
looked at length into the concentration and distribution of the OTR in the brains of rats 
and mice, as well as a limited amount of studies investigating the OTRs of primates 
(Boccia et al., 2001).  The species of primates include rhesus monkeys, squirrel monkeys, 
tree shrews, marmosets, and humans (Jenkins et al., 1984, Sofroniew et al., 1981, Caffe et 
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al., 1989 and Wang et al., 1997).  In these species, including humans, OT neuronal 
projections have been found in many identical brain areas as the rat, mouse, and sheep, 
specifically the amygdala and several brainstem nuclei. However, the interspecies 
differences between animals and humans are significant enough, especially in relation to 
brain structure, to warrant a more conclusive human based study.  While similarities 
between mice, rats and human brain structures exist, and many structures and functions 
are conserved across species, understanding the specific concentration and distribution of 
OTR in the human brain is critical to further investigating the proposal of this study.  
Boccia et al. provided a key study to better identifying the localization of OTR in the 
human brain. 
 The study by Boccia et al. (2013) called into question the autoradiographic 
technique of identifying the OTR using ornithine vasotocin, as it has been found to act 
like vasopressin, a chemically similar hormone to OT, binding to the vasopressin receptor 
(AVPR) just as potently as it does to OTR (Toloczko et al., 1997).  Specifically, the 
results of studies by Loup et al., 1989 and 1991, which utilized autoradiographic 
techniques to study OT binding in the human brain, was what was being questioned.  
These two previous studies had found OT binding in many areas that were similar to 
other animal models, but a key area that they did not find any OTR localization was in 
the amygdala, and area of the brain that is essential in regulating many of the behaviors 
that OT seems to have a very large impact on, as will be explained later in this paper.   
 Utilizing IHC instead of autoradiography, the monoclonal antibody 2F8 was used 
to identify the distribution of OTR in the female human brain.  Antibody 2F8 has been 
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found to be an effective antibody for the purpose of identifying OTR in human 
reproductive tissue as well as OTRs in cynomologous monkey brains, and more 
specifically, there was no cross binding with the AVPR as was the case with previously 
done studies (Wakasa et al., 2009; Boccia et al., 2001).  As shown in Table 3, the degree 
of OTR distribution varies widely over the different regions of the brain.  The areas of 
significance for this study will be analyzed further in a later section, once some of the 
behavioral components of OT have been discussed.  But as clearly displayed in Figure 4, 
the amygdala, cingulate cortex, and the raphe nucleus are some of the areas where OTR 
are clearly located, while the hippocampus does not display any OTR staining. 
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Table 2. OTR Concentrations in Human Brain Regions.  Listed are the areas of the 
human brain that were stained with 2F8 monoclonal antibody for OTRs, and each brain 
area was examined by 3 independent observers. Abbreviations:-+++ heavy; ++ moderate; 
+ light staining: − no staining observed (Table taken from Boccia et al., 2013) 
 
 
 
 
 
 
21 
 
 
 
Figure 4.  Human Brain Regions Stained for OTR.   Shown is a visual representation 
the areas of the human brain that were stained for OTRs with 2F8 monoclonal antibody. 
The amygdala and cingulate cortex are examples of areas heavily populated with OTR, 
with the hippocampus and raphe nucleus are examples of areas without any OTR 
staining.  Displayed is also a control study showing the selectivity of 2F8 to OTR, and 
that is does not bind to AVPR (shown as V1a subtype) (Figure taken from Boccia et al., 
2013) 
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Behavioral Effects of Oxytocin 
The lesser known of OT’s functions resides within the brain, and is the area of 
importance for this current study.  Through interactions with various areas of the brain, 
OT has a role in many behavioral effects, including regulating maternal behavior, 
increasing trust, lowering stress, modulating sexual behaviors, enhancing ability to read 
social cues, enhancing memory, and facilitation of pair bonding (Abdel-Razek, and 
Bennasir, 2010).  Each one of these behavioral effects of OT would be altered or 
enhanced further by the amplification, redistribution, or modification of the levels of 
central OT or centrally located OTR.  It is therefore necessary to validate the claims that 
central OT does in fact play a key role in these behaviors. 
Maternal Behavior 
Closely linked to birth and lactation, maternal behavior appears to be influenced 
to some degree by OT.  It is well documented that OT is a key hormone in parturition, 
providing powerful uterine contractions that increase in frequency and intensity as a 
mother undergoes delivery of the baby.  This high peripheral level of OT serves an 
obvious role in interacting with the uterine smooth muscle, but coinciding with this high 
level of circulating OT is an elevated OT concentration in the central nervous system that 
is believed to help the mother form a strong sense of attachment to its child upon delivery 
(Bell, Erickson and Carter, 2014).   In rats, it has been observed that during periods of 
elevated peripheral OT, there is a correlating rise in central OT levels (Neumann et al., 
2006).  Given that during birth, there is an elevated level of OT in the bloodstream to aid 
in uterine contraction and expulsion of the baby, it is thought that the level of OT in the 
23 
brain increases during birth as well.  This elevated level of central OT is thought to play a 
key role in facilitating mothering behaviors, which include affectionate touch, positive 
affect, affectionate language (in humans), and eye-to-eye contact (Gordon et al., 2010). 
Mothering behavior tied to OT has been demonstrated in a few animal models.  In 
rats, ewes, non-human primates and prairie voles, manipulating the OT/OTR system has 
resulted in conclusive evidence linking OT to successful maternal behavior.  In all animal 
cases, synthetic OT administration promoted motherly behavior, while OTR antagonists 
decreased the degree of motherly behavior (Boccia et al., 2007; Keverne and Kendrick, 
1992; Pedersen et al., 1994).  There have also been a number of studies that have found a 
strong link between abnormally low levels of OT, which correlate with central OT, and 
decreased optimal mothering behavior (Gordon et al., 2010).  In cases of genetic variation 
of the OTR gene that result in decreased central binding capacity of the OTR, there was 
also a decrease in optimal mothering behavior (Francis et al., 2002; Feldman et al., 2012).   
In a recent study that utilized fMRI scans of 15 mother-child pairs, two distinct “brain-
behavior-oxytocin profiles” were discovered in the mothers whom either demonstrated 
maternal synchronicity or maternal intrusiveness.  Maternal synchronicity was defined as 
appropriate coordination of mothering behaviors with the infants signals, while maternal 
intrusiveness was defined as inappropriate and excessive expression of maternal 
behavior, not necessarily lining up with the cues of the infant (Atzil, Hendler, and 
Feldman, 2011).  The mothers who displayed maternal synchronicity upon interacting 
with their infant had higher plasma concentrations of OT, as well as higher activity in the 
nucleus accumbens (NAcc), an area of the brain associated with the reward motivation 
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pathways of the brain.  Mothers who displayed intrusive maternal behavior had lower 
circulating levels of OT and the amygdala activity was elevated, suggesting a higher state 
of anxiety and stress motivation pathways of the brain (Atzil, Hendler, and Feldman, 
2011).  While measurements of central OT in human mothers would be even more 
conclusive evidence of the role of OT in maternal behaviors, the existing studies provide 
a substantial argument for the significance of OT in human maternal behaviors. 
Sexual Behaviors 
OT has been linked to sexual behavior, very strongly in animal models, and to a 
degree in humans.  There have been many studies in animals done where OT is 
administered, the sexual behavior, such as mounting, is measured, and then an OT 
antagonist is administered, and the sexual behavior diminishes (see Table 3) (Carter, 
1992).  In female rats, OT administration results in the lordosis position, a sexually 
receptive position that a female willing to mate takes in order for the male to mount 
(Arletti and Nertolini, 1985). Once an OT antagonist was administered, the frequency of 
lordosis decreased (Witt and Insel, 1991).   
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Table 3. Effects of Oxytocin and Oxytocin Antagonist on Sexual Behavior in Male 
Rats.  Oxytocin (OT) and Oxytocin antagonists (OTA) administered to male rats in 
varying dosages, and the resulting sexual behaviors.  Upward arrow = increase in 
behavior, downward arrow = decrease in behavior.  IV = intravenous, IP = 
intraperitoneal, ICV = intracerebroventricular, PVN = paraventricular nucleus, PEI = 
postejaculatory interval prior to resumption of mounting (table taken from Carter 1992). 
 
 
 
 
 
In humans, OT is released during orgasm in both males and females and in 
females the release of OT shows a positive relationship with the intensity of muscle 
contraction (Kruger et al., 2003 and Murphy et al., 1987).  Using intranasal OT, it has 
been shown that OT can cause increased sexual arousal in females, cause orgasms in 
previously anorgasmic males, improve sexual function in males with social anxiety, and 
trigger an enhanced release of plasma catecholamines, leading to an enhanced perception 
of arousal in males during masturbation (Anderson-Hunt and Dennerstein, 1994; 
Anderson-Hunt and Dennerstein, 1995; Ishak et al., 2008; and Burri et al., 2008).  It is 
clear that OT impacts sexual behavior differently depending on the sex of the individual, 
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showing the general pattern of generally affecting performance level in males, including 
erectile function, sexual satisfaction and orgasm, while in females, OT seems to play 
more of a role in the emotional aspects of the sexual relationship (Fischer-Shofty et al., 
2013).  For example, in a double blind study where OT and a placebo were administered 
and partners had sexual intercourse, male patients in the study reported increased 
intensity of orgasm and increased sexual satiety after intercourse.  Females in the study 
reported increased relaxation and increased ability to interact and empathize with their 
partner following intercourse (Behnia et al, 2014). 
Social Cues 
OT seems to play a large role in aiding individuals in their ability to read social 
cues.  OT has been shown to facilitate pro-social behaviors such as social memory, 
recognition of socially salient cues, and increased eye contact, all of which are impaired 
to some degree in individuals with autism spectrum disorders (ASD) (Baskerville & 
Douglas, 2010).   Following this line of thought, a research team led by Elissar Andari at 
the National Center of Scientific Research in Bron, France successfully improved the 
social behavior in high-functioning autistic spectrum disorder (HF-ASD) patients using 
intranasally administered OT (Andari et al., 2010).  HF-ASD is in the sphere of the ASDs 
that has its deficits localized in understanding social cues and responding to them, while 
language and intellectual abilities are fairly average.  This study has opened up a whole 
new field of possibilities, and with it, a new array of questions. 
 If OT can help in autism, is there something wrong with the levels of OT in ASD 
patients in the first place?  This question was analyzed by quite a few studies, resulting in 
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some stunning conclusions.  While the issue may be, in part, the levels of OT in ASD 
patients being lower, the root of the problem seems to stem from the genetic expression 
of the OTR.  Much as with OT, OTR was long identified to be located in uterus tissue 
and mammary glands, but recently the prevalence of OTR in the brain have become 
better understood, correlating with the host of behavioral effects it has (Baskerville and 
Douglas, 2010). It seems that while there is only one gene for the OTR, there are a few 
different phenotypes expressed for the OTR.  This variation occurs due to a number of 
different single point mutations along the DNA for the receptors, which are known as 
Single Nucleotide Polymorphisms (SNPs). These SNPs have different alleles that result 
in the expression of varying phenotypes of the OTR, whose differences relate to the form, 
functionality and distribution of the OTR (Kogan et al., 2011).   
 One particular SNP, rs53576, and its two alleles, G (long version) and A (short 
version), has been identified to play a large role ASD and its relation to empathy.  In 
2009, a research team found that individuals that were homozygous for the G allele of 
rs53576 showed higher levels of empathy and lower levels of reactivity to stress than 
those who were GA heterozygous or AA homozygous (Rodrigues et al, 2009).  In a 
follow-up study two years later, researchers set out to determine whether people could 
detect the varying levels of empathy, and if those observations correlated with the 
varying expressions of the G and A allele.  If the difference in social function was so 
small that it could not be picked up by strangers, then the relative influence of the 
variants of the rs53576 SNP was most likely very insignificant.  To figure this out, the 
research team listened to 23 different romantic couples discussing an emotionally 
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challenging period in their life and viewed a corresponding video of the partner of the 
couple who was listening and responding to the narrative told by the other partner.  The 
researchers, blind to the genotypes, determined the highest point of emotionality and 
made a 20 second silent clip of that moment.  The researchers then had participants rate 
the pro-sociality (empathy) of the videotaped individuals.  As expected, the participants 
rated carriers of the A allele (heterozygous and homozygous) as less pro-social than the 
GG homozygous individuals, showing the significance of the different alleles of the 
rs53576 SNP (Kogan et al., 2011). 
 Researchers were curious about the potential connection between ASD patients 
and OTR SNPs, and investigated further.  In one study done at the Institute of Mental 
Health at Peking University, Beijing, China, researchers genotyped 195 autistic patients, 
looking at four SNPs of the OTR, finding that, in fact, the rs53576 SNP was significantly 
associated with those autistic patients (Wu et al., 2005). In a similar study conducted in a 
Caucasian autistic cohort, researchers looked at two SNPs, rs53576 and rs225498.  In this 
study, there was no relationship between the rs53576 SNP, as seen in the Chinese cohort, 
but rather a significant relationship between the rs225498 SNP of OTR (Jacob et al., 
2007).  This shows that while the genetics of OTR are clearly important in its role in 
ASDs, interethnic differences, among many other variables, must also be considered. 
 The genetic role of OT has been explored, and a connection has been made 
between OTR SNPs and those with ASD; but what of the practical use of OT in patients 
with ASD?  The findings of Andari and his co-researchers’ in France poses exciting 
potential.  In 13 patients with HF-ASD, decision making and affect in a social interaction 
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game were looked at, as well as amount of time gazing at socially valiant facial regions.  
For decision making, the methods used were a social ball tossing game, where three 
virtual players could toss a ball to the participant.  The “good” player would toss the ball 
to the participant instead of the other virtual players 70% of the time, the “neutral” 30% 
and the “bad” 10%.  Healthy patients would preferentially toss a ball to the “good” 
player, due to the positive “social interactions.  HF-ASD placebo patients showed no 
significant preference for any of the players, but after receiving intranasal administration 
of OT, they showed a significant preference towards the “good” player.  They also 
reported a higher sense of trust and preference towards the “good” player (Andari et al., 
2010).   
Those given OT also increased gaze time on socially relevant areas of the face, 
namely the eyes, compared to when given the placebo.  For ASD, poor eye gaze is often 
an issue, and reading social cues depends on the ability to look at and interpret facial 
expressions, so this finding is very promising for ASD patients.  A similar study by 
Guastella et al. (2010) showed that OT administration increased performance on the 
Mind in the Eyes Test-Revised (RMET), which tested the ability to read emotions from 
the eyes of subtle affective facial expressions.  This supports the idea that OT can 
enhance the ability to interpret facial expressions and correctly infer social cues and 
emotions.   
How OT enhances such social interactions such as increased eye contact is not 
well known, but certain studies have looked at the role of the amygdala, and OT’s 
influence on it.  The amygdala is a small region of the brain associated with recognition 
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of fearful stimuli.  The idea is that in individuals with ASD, the amygdala acts to create 
an inhibiting social effect, such as a fear of making eye contact ad looking at faces to 
interpret social cues.  The amygdala also has a high density of OTR’s, and when OT 
binds to it, the activity of the amygdala is drastically reduced.  Therefore it has been 
hypothesized that OT acts to encourage pro-social behavior through inhibiting the fearful 
reactions of the amygdala, making individuals more outgoing, open, and engaging with 
those around them (Hurlemann et al., 2010). 
Trust 
OT’s role in trust has become an area of heavy research recently.  Its implications 
in not only enhancing the quality of interpersonal relations, but also enhancing business 
relations and the financial ramifications that follow have drawn much attention to OT.  A 
study by Kosfeld et al. (2005) showed that intranasal OT spray increased individual’s 
willingness to trust others, and that this effect was not from an increased acceptance of 
taking risks, but rather from an increased acceptance to take social risks.  The social 
aspect of OT has been continually tested through two trust games.  The first is where two 
subjects that are interacting anonymously are playing the role of an investor and a trustee.  
The investor is given the choice of making a costly trusting decision by giving money to 
the trustee.  If the investor transfers the money to the trustee, the total amount of money 
available for the two subjects increases due to the experimenter tripling the investor’s 
transfer.  However, initially all of that now tripled money goes to the trustee.  The 
experimenter then informs the trustee that the investor made this transfer and that the 
trustee can honor the investor’s trust by sending back money so that both of the subjects 
31 
can earn the same amount of money.  If the trustee does this, both the investor and the 
trustee end up with equal, and higher sum money than they started with.  The trustee also 
has the option of not sharing the investor’s money upon receiving the transfer of funds, 
thus betraying the investor’s trust.  This scenario is seen as a breach of trust by the 
investor (Bohnet and Zeckhauser, 2004). A selfish trustee will never share the money, 
since it is a costly decision for them and the investor and trustee only interact once, but in 
doing so, they do not honor the investor’s trust. 
In the second game, the risk game, the only difference is that a computer program 
randomly generates the payback, thus no interaction with the trustee takes place.  So the 
risk that the investor takes is not based on whether to trust the trustee or not, as in the first 
trust game, but rather on whether the investor’s risk is based on a nonsocial, random 
computer program.  The risk game acts as a control game for the first trust game, and 
evidence has shown that people avoid being betrayed when they trust another person, but 
this aversion to betrayal does not occur in nonsocial risks, such as the second game 
(Bohnet and Zeckhauser, 2004).  OT administration to the investor showed an increased 
likelihood of the investor taking the social risk in the first trust game, but no significant 
increase in taking the nonsocial risk of the second risk game.  This suggests that OT 
increases trust in another individual but not nonsocial risk taking (Kosfeld et al. 2005).    
This was observational data, so researchers wanted to conduct similar studies, but 
to use neuroimaging to confirm the areas of the brain involved with the behavioral 
changes in trust in its relation to OT, specifically, the level of activity in the amygdala.  It 
has been shown that in individuals who exhibit social avoidance and social phobias, as 
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well as in individuals who are viewing untrustworthy faces, there is an increased 
activation of the amygdala (Stein et al., 2002, Tillfors et al., 2001, Winston et al., 2002).  
As mentioned earlier, the proposed mechanism of OT interacting with the amygdala was 
to bind to the high density of OTR located in that brain region and upon binding, 
decrease the activity of the amygdala.   
Baumgartner et al., (2008) carried out the two games, the trust game and the risk 
game, while having the investors split into an intranasal OT group and an intranasal 
placebo group.  The investors’ brain activity was analyzed using a functional magnetic 
resonance imaging (fMRI) machine during the decision making step of each game.   The 
researchers then generated statistical maps that contrasted the OT and the placebo groups 
using the serial subtraction terms of either trust > risk or risk > trust.  This allowed for the 
brain map to reveal areas of the brain that were activated specifically to trust taking 
activities (Figure 5).   
The specific neurological findings from that study show that the OT treated 
subjects’ amygdala was far less active after making the decision in both games than the 
placebo treated subjects.  The subjects treated with the OT nasal spray exhibited a 
significantly higher degree of trusting behavior, while those with the placebo did not 
exhibit a significant increase in trusting behavior.  Another key finding was that both 
subjects in the OT and placebo group did not change their willingness to take risks in the 
risk game, when it was a nonsocial risk that they were taking.  This reinforces the idea 
that OT does not increase general risk taking, but rather directly affects the level of trust 
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between individuals, since the OT subjects in the trust game, which focused on a social 
risk, were more willing to trust than the placebo group (Baumgarter et al., 2008) 
 
 
Figure 5. Amygdala Activity for Trust Test.  Left and right amygdala activity, 
determined by a fMRI imaging system.  Green represents the placebo treatment, while 
red represents the OT treatment.  Pre-Feedback indicates the amygdala’s activity prior to 
experiencing the trust game, and Post-Feedback indicates the amygdala’s activity 
following the trust game (Figure taken from Baumgarter et al., 2008). 
 
 
Another interesting area of the study was in the activity level of the caudate 
nucleus following OT administration.  Previous studies (O’Doherty et al., 2004; Tricomi 
et al., 2004) showed, through neuroimaging, that the caudate nucleus a key player 
involved in feedback processing and reward learning associated with behavioral 
adaptations to stimuli and information in relation to action-outcome scenarios.  It has 
been documented that the caudate nucleus activity decreases as learning progresses, and 
the rewards of certain scenarios can be more reliably predicted (et al., 2005).  This means 
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that after individuals learn the relationship between their actions and the associated 
consequences and outcomes, the caudate nucleus is less active.   
A neuroimaging study by Delgado et al. (2005) utilized the same trust game in 
order to investigate the effect of perception of a morally good, morally bad or morally 
neutral individual on the activity of the caudate nucleus.  The relative morality was 
designated by describing morally good, bad and neutral behaviors, and assigning those 
three behaviors to three different faces that were presented to the subjects.  Subjects in 
the study were more likely to trust the morally good partner, thus behaving as they knew 
that the good partner was more trustworthy, and were less likely to trust the morally bad 
partner, behaving as if they knew the morally bad partner was less trustworthy.  The 
activity of the caudate nucleus when trusting the morally good partner, and to a lesser 
extent when not trusting the morally bad partner, was significantly decreased.  In 
contrast, the caudate nucleus activity was strongly activated when deciding whether to 
trust the morally neutral partner.  The activity of the caudate nucleus for trusting the 
morally good partner was so diminished because the subject did not have to exert much 
energy into deciding whether or not to trust the morally good partner or not, rather they 
just implicitly knew they could trust based on the judgment of the partner’s morals.  
However, when the subject was presented with the challenge of trusting the morally 
neutral partner, the caudate nucleus was very active, since they subject had to decide 
whether or not to trust the morally neutral partner.  Because the consequences of the 
action of trusting the morally neutral partner was not as predictable, the caudate nucleus 
was much more active for this partner (Delgado et al., 2005). 
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What is interesting about the inactivity seen in the caudate nucleus after OT 
administration in the study by Baumgartner et al. (2008) is that just like in Delgado et al. 
(2005), where the subject had explicit knowledge of facing a morally good partner, the 
activity of the caudate nucleus is decreased as well.  This suggests that subjects given OT 
behave as if they know that they can trust the partner that they are playing the game with, 
since trusting their partner indicates that they believe they know what the outcome will 
be.  Thus they believe they know the outcome of their action, in this case, trusting the 
individual after OT administration, just like an individual from Delgado’s study could 
predict the outcome of dealing with a morally good partner.  It becomes clear form this 
comparison that OT’s influence on trust not only acts through decreasing the activity of 
the amygdala, but also through decreasing the activity of the caudate nucleus, lowering 
the need to adapt and anticipate consequences, and allowing for an implicit trust of 
others. 
Anxiolytic effects  
 OT has been reported to play a role in decreasing fear and anxiety in humans.  
During public speaking, anxiety has been reported to be drastically reduced after just a 
single does of intranasal OT administration (de Oliveira et al., 2012).  In patients with 
Post Traumatic Stress Disorder (PTSD), OT has proven to be of potential therapeutic use, 
decreasing acute anxiety, increasing mood and desire for positive social interactions, as 
well as decreasing the severity of PTSD symptoms (Yatzkar and Klein, 2010).  Another 
PTSD study with OT administration showed that patients exhibited decreased 
physiological reactions upon being presented with combat imagery (Pitman et al, 1993). 
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The amygdala plays a central role in fear and anxiety, as discussed above, and has a high 
density of OTR.  OT’s ability to dampen the amygdala’s activity decreases the output of 
the amygdala to brainstem areas and the hypothalamus.  This dampening of activity 
occurs via OTR activation through binding of OT leading to the activation of GABA-
ergic interneurons which specifically act as inhibitory neurons in the amygdala, 
attenuating the fear and anxiety responses derived from the amygdala (Viviani et al., 
2011).   
With a dampened amygdala output to the hypothalamus, the hypothalamic-
pituitary-adrenal (HPA) axis ability to respond to stress in inhibited significantly 
(Neumann et al., 2000).  In a study of 37 men, two groups were treated with or without  
intranasal OT and exposed to social stress; subsequently the salivary cortisol levels were 
measured post stress.  Those treated with OT showed a significantly lower level of 
cortisol, indicating that OT’s influence over the HPA axis is significant enough to lower 
the downstream adrenal production of the stress hormone cortisol (Heinrichs et al., 2003).  
It also appears that OT aids in fear and anxiety attenuation through increased connectivity 
between the prefrontal cortex (PFC) and the amygdala in healthy patients, while at the 
same time attenuating PCF hyperactivity, specifically the ventromedial PFC (vmPFC), in 
patients with general anxiety disorder when presented with sad or alarming images 
(Labuschagne et al., 2011).  This stronger connectivity between the vmPFC could 
possibly be for the purpose of increased top down control of fear and anxiety responses 
from the more analytic and rational PCF, rather than bottom up from the reactionary, 
irrational amygdala (see Figure 6).  From these studies it is clear that OT poses as a 
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potentially useful therapeutic treatment for major anxiety disorders such as PTSD, and 
that any modulation of this system via ingestion of soy could have major impacts on 
individuals with these disorders. 
 
 
Figure 6.  Modulation of the Fear and Anxiety Response by OT.   OT acts to inhibit 
the effects of the amygdala while strengthening the control of the vmPFC, leading to an 
attenuation of the fear response.  vmPFC – ventromedial prefrontal cortex, SNS = 
sympathetic nervous system, HPA = hypothalamic-pituitary-adrenal axis, PTSD =  
posttraumatic stress disorder, + = stimulating, - = inhibiting.(Figure taken from Olff et 
al., 2010) 
 
Pair Bonding 
In monogamous prairie voles, wide ranges of experiments have been done to 
explore the role of OT in pair bonding.  Early on, it was seen that intranasal 
administration of OT increased monogamous behaviors in already monogamous prairie 
voles (Insel and Hulihan, 1995).  This was one of the first studies looking at the role of 
OT in something other than parturition and milk letdown, and from there, many studies 
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followed. It soon became clear that sexual interactions raised OT levels in rodents, and 
OT’s role in pair bonding and sexual behavior became more prevalent in the literature 
(Waldherr and  Neumann, 2007).  There are the classic experiments, linking the density 
of OTR and AVPRs to the frequency of monogamy in vole species, showing the higher 
the density of the receptors, the greater the expression of monogamous behaviors (Carter 
et al., 1995; Young et al., 1999).  There also is a wide distribution based difference in 
OTRs between monogamous prairie voles and polygamous meadow voles, prairie voles 
showing a higher density localized on the PFC and the nucleus NAcc, while the meadow 
vole has a higher density of OTRs on the ventromedial hypothalamus (Insel and Shapiro, 
1992; Young et al., 1996; Smeltzer et al., 2006).  But these studies are correlational, 
relating density and distribution to degree of monogamous behavior.   
These are important studies to show a relationship, but experimental manipulation 
is needed to be sure that it is in fact the OTR that are effecting monogamy, and not just a 
bi-product of monogamy.  One very effective method to attribute pair bonding to OTRs is 
to use genetically engineered rodents (voles or mice) to see the behavioral effect of using 
OT or OTR knock out (K.O.) animals.  Fortunately these studies have been done in mass.  
Monogamous males also have a higher density of OTRs in the hippocampus and 
septohippocampal nucleus, which are both associated with spatial memory (Ophir et al., 
2012).  This suggests that OT plays into the role of spatial memory in a monogamous 
mating strategy.  For monogamous species, a greater spatial memory would be important 
for facilitating easier recall of a mate’s location, or increased efficiency in foraging for 
food, as to be able to return to the mate faster.  This reinforces ideas above of OT 
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influencing memory. 
 It is important to dive further into how, mechanistically; it is thought that OT 
influences pair bonding.  Dopamine (DA) seems to play a strong role in all of this.  But 
what is the link between OT and DA?  On the level of neuroanatomy, a simultaneous 
activation of the OT system within the brain and the mesolimbic dopaminergic pathway 
is believed to occur.  In this pathway, the VTA projects dopaminergic neurons onto the 
PFC and NAcc, resulting in the feeling of reward and wanting (Young et al., 2005).  D1 
and D2 receptors, the two receptors of the mesolimbic dopaminergic pathway, play 
significant, but different roles.  Both are G-protein coupled receptors, with D1 a Gαs, or 
stimulatory, and D2 a Gαi, or inhibitory, in their ability to regulate protein Kinase A 
(PKA).  
In the presence of presence of DA, D1 activation prevents pair bond formation, 
while D2 facilitate and reinforce pair bond formation, as shown in Figure 7 (Gingrich et 
al., 2000). What seems to occur, is that in the presence of PKA, the pleasure driven 
association between the mated individual and the sensation of pleasure are not linked.  In 
contrast, when the PKA levels are lowered, an association is allowed to form between the 
mated individual and the sensation of pleasure, resulting in a pair bond.  After male 
prairie voles mate, the density of D1 receptors increases on the NAcc, and inhibits a new 
bond from being formed with a new individual (Young and Wang, 2004).  The combined 
reinforcement of the already established bond with the inhibition of new bonds is where 
the monogamous behavior is believed to stem from. In the prairie voles, it was shown 
that the DA receptors that played this role in pair bonding were located specifically on 
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the rostral shell of the NAcc, but not within the core or caudal shell (Aragona et al., 
2006). To experimentally demonstrate how OT and DA are simultaneously linked to pair 
bonding, in female prairie voles, blockage of either OT or DA receptors resulted in an 
inability to form pair bonds (Liu and Wang, 2003).  This shows that both OT and DA 
must be activated to facilitate and undergo a pair bond. 
 
 
 
Figure 7. Dopamine Receptors Role in Pair Bonding. Activation of D2 receptors via 
dopamine inhibits the formation of pair bonding between two prairie voles following 
matting (a) while the activation of D1 receptors via dopamine facilitates the formation of 
strong pair bonding between prairie voles following mating (b). (Figure taken from 
Gingrich et al., 2000). 
 
 
To experimentally demonstrate how OT and DA are simultaneously linked to pair 
bonding, in female prairie voles, blockage of either OT or DA receptors resulted in an 
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inability to form pair bonds (Liu and Wang, 2002).  This shows that both OT and DA 
must be activated to facilitate and undergo a pair bond. 
OT and ER Relationship 
For a better understanding of just how phytoestrogens could potentially modulate 
OT and OTR in the brain, the estrogen-OT relationship must be described in full.  For 
phytoestrogens that act estrogenically in the body, it can be assumed that they influence 
OT in a similar way as estrogen, acting through the same regulatory mechanisms.  This 
mechanism is through the ERs in the brain.  ERα than ERβ are the two receptor types and 
have been shown to be the linking piece between estrogen and OT.  When ERα is bound 
by estrogen, it begins the synthesis of OTR in that region of the brain, and when ERβ 
binds to estrogen, it begins to synthesize OT in that area of the brain.  In areas of the 
brain where ERα than ERβ are both present, they combined result of OT and OTr 
synthesis acts synergistically, providing more OTR to yield OT driven behaviors, as well 
as more OT to initiate this process by binding to the new OTRs (Rissman, 2008). 
Phytoestrogens have been shown to bind to both ERα than ERβ, and have potent 
transactivation activity compared to naturally occurring estrogen (Kuiper et al., 1998).  
Given this, following ingestion of soy and increased phytoestrogen concentrations in the 
brain, it is very possible for phytoestrogens to bind to both ERα than ERβ and induce the 
synthesis of both OTR and OT, respectively.  This is the proposed mechanism for how 
phytoestrogens from ingested soy eventually leads to changes in OT driven behavior. 
Another key part of the puzzle is conclusive evidence that a diet rich in 
phytoestrogens can in fact increase the distribution or concentration of OTR in the brains 
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of humans.  While for obvious ethical reasons, a proper controlled experiment on humans 
is difficult to do, a very well done animal study was recently published.  Yoshimura and 
colleagues took the brains of twenty male and twenty female mice, aged 5-6 days and  
incubated them in a culture medium used to mimic cerebral spinal fluid.  Then either 
estradiol, diadzein, genistein, or a control was added to the medium and the whole 
medium was replaced two times a week.  After a two-week treatment, the 400 μm thick 
coronal sections were processed for IHC anti-OT antibody staining for OT.  Once 
stained, the digital images of the OT-immunoreactive neurons were captured on an 
optical microscope, and two to three slices of the supraoptic nucleus (SON) and 
periventricular nucleus (PVN) from each neonatal brain were analyzed.  The number and 
diameter of the OT positive cells, as well as frequency of varicosity of the OT neural cell 
dendrites were measured (Yoshimura, Yamamoto, and Endo, 2011). 
The PVN and SON are the key areas in the brain that are responsible for the 
production of centrally released OT, and an increase in size of the neurons in those brain 
areas would have a direct effect on the amount of OT produced in the brain.  Because of 
their significance in central OT   From this study there were three key findings in relation 
to how isoflavones altered brain morphology of early postnatal mice.  The first finding 
was that genistein actually decreased the size of OT neurons in the SON of male mice, 
which suggests that it acts through a mechanism other than interaction with the ER’s (see 
Figure 8).  Genistein is also a protein tyrosine kinase inhibitor, and protein tyrosine 
kinase is a key regulator in cellular growth and differentiation.  It is therefore plausible 
that the seemingly antiestrogenic activity of genistein in males is from the inhibition of 
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protein tyrosine kinase’s ability to induce cell growth in OT neurons.  Diadzein does not 
seem to be a significant protein tyrosine kinase inhibitor, so acting through this 
mechanism is less likely (Yoshimura, Yamamoto, and Endo, 2011).  There was no size 
change of OT neurons in the SON of females with genistein, nor in the PVN for either 
male or female in the presence of genistein.   
The second key finding of this study by Yoshimura was that estrogen and 
diadzein both increased the frequency of varicosity in small OT neurons of the PVN (see 
Figure 9, Q).  Small OT neurons were defined as neurons whose cell body diameter was 
less than 21 μm.  The increased varicosity demonstrates that the reach and expansion of 
the dendritic spindles of the OT neurons in the PVN increased, allowing for more neuron-
to-neuron interaction in these female mice’s brains.  It also means that the ability of the 
PVN to release OT into the brain is increased due to its more expansive neuronal 
network.  This finding does not necessarily mean that more OT is produced and 
distributed, but it does mean that the PVN has an advanced capability to distribute OT in 
the brain.  This increase in varicosity was not found in male mice PVN for estrogen or 
diadzein, and in neither male nor female PVN for genistein (Yoshimura, Yamamoto, and 
Endo, 2011).   
The third finding of the Yoshimura study was that estrogen, diadzein and 
genistein all induced vacuolation of OT neurons, more frequently in males than in 
females, and in the SON more than the PVN.  This increase in vacuolation of the OT 
neurosecretory cells means that in the presence of estrogen, or isoflavones, the amount of 
OT produced in the mouse brain increased, since each one of these vacuoles within the 
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neuron contained a concentrated amount of OT to be released into the brain.  In the 
female PVN, there was no significant difference between the control, estrogen, and the 
two isoflavones, but the vacuolation was significantly lower in the females compared to 
the males.  In the male PVN, estrogen and genistein caused significantly more 
vacuolation than the control or diadzein.  Both male and female PVN vacuolation was 
less than the SON vacuolation in both genders.  In female SON, diadzein caused 
significantly more vacuolation than estrogen, and estrogen significantly more vacuolation 
than genistein or the control. In males, both estrogen and diadzein caused significantly 
more vacuolation than genistein, and genistein caused significantly more vacuolation 
than the control.  The vacuolation in the male SON overall was more significant than the 
SON vacuolation in the female (Yoshimura, Yamamoto, and Endo, 2011).  While 
interpreting the results of this finding can be complicated, the main takeaways are that 
both diadzein and genistein have the potential to induce an increase in OT production 
through vacuolation of OT neurons, and that there are significant sexual differences in 
how these isoflavones affect the OT production. 
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Figure 8. OT Neurons in the SON in the presence of Estrogen or Isoflavones. Slices 
of the SON of mice were cultured for two weeks, either with estrogen, isoflavones, or 
neither. A–H show photomicrographic images of OT positive neurons in the PVN, with 
the arrowheads indicating vacuolated OT positive cell bodies. (A and B) = control, (C 
and D) = estrogen, (E and F) = diadzein, and (G and H) = genistein. (A, C, E, and G) = 
female and (B, D, F, and H) = male. The histograms show size distribution, in μm, of OT 
neurons in the PVN. (I and J) = control, (K and L) = estrogen , (E and F) = diadzein, (G 
and H) = genistein. (I, K, M, and O) = female and (J, L, N, and P) = male.  The numbers 
inserted onto the histogram = total number of analyzed OT neurons. (Q) = The bar graphs 
show the mean size of OT neuron cell bodies, in μm, in the SON. CNT = control, E2 = 
estrogen, Dzd = diadzein, Gen = genistein.  Female: n = 4 control, 4 estrogen, 4 diadzein, 
3 genistein. Male: n = 4 control, 3 estrogen, 4 diadzein, 4 genistein. *Significant 
difference vs. corresponding CNT (P < 0.05).  (Figure taken from Yoshimura, 
Yamamoto, and Endo, 2011). 
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Figure 9. OT Neurons in the PVN in the presence of Estrogen or Isoflavones. Slices 
of the PVN of mice were cultured for two weeks, either with estrogen, isoflavones, or 
neither. A-H show photomicrographic images of OT positive neurons in the PVN, with 
the arrowheads indicating vacuolated OT positive cell bodies. (A and B) = control, (C 
and D) = estrogen, (E and F) = diadzein, and (G and H) = genistein. (A, C, E, and G) = 
female and (B, D, F, and H) = male. The histograms show size distribution, in μm, of OT 
neurons in the PVN. (I and J) = control, (K and L) = estrogen , (E and F) = diadzein, (G 
and H) = genistein. (I, K, M, and O) = female and (J, L, N, and P) = male.  The numbers 
inserted onto the histogram = total number of analyzed OT neurons. (Q) = The bar graphs 
show the mean size of OT neuron cell bodies, in μm, in the PVN. CNT = control, E2 = 
estrogen, Dzd = diadzein, Gen = genistein.  Female: n = 6 control, 4 estrogen, 4 diadzein, 
5 genistein. Male: n = 5 control, 4 estrogen, 4 diadzein, 4 genistein.  (R) = Bar graphs 
showing the mean ratio of large (PVN-L; ≥21 μm, darker lower column) to small (PVN-
S; <21 μm, white upper column) oxytocin-neuronal cell bodies in PVN (female: n = 6 
control, 4 estrogen, 4 diadzein, 5 genistein; male: n = 5 control, 3 estrogen, 4 diadzein, 
and 4 genistein). (Figure taken from Yoshimura, Yamamoto and Endo, 2011). 
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 While not a direct link between phytoestrogens and OT, the study by Lephart et 
al. (2002), mentioned earlier, found behavioral changes that are linked to OT.  However, 
the study was not investigating OT driven behavior, but rather was looking at the 
neurobehavioral effects of dietary soy.  In the study, along with the morphological 
changes to the SDN-POA mentioned earlier, there was an observed anxiolytic effect on 
the rats when tested in an elevated maze in the rats fed a phyto-rich diet when compared 
to the rats fed a phyto-free diet.  There was no significant difference between sexes in 
relation to anxiety, but the level of anxiety exhibited was significantly higher for those 
rats fed a phyto-free diet when compared to those fed a phyto-rich diet.  The elevated 
maze test is a proven test that assesses the level of stress in rats (Pellow et al., 1985).   In 
the test,  rats will usually avoid entering into or spending time in open arms of the maze, 
in an anxiety driven aversion to a novel environment for fear of danger from exploration.  
However, when the rat is less stressed, it will spend more time exploring the open arms of 
the maze.  In this study, both male and female rats fed the phyto-rich diet spent a 
significantly longer time exploring and entered more open arms of the maze than the rats 
fed the phyto-free diet. 
 The study suggests this anxiolytic effect could be due to interactions with the 
GABA receptor.  The GABA receptor is known to produce antianxiety behaviors when 
bound by chemicals such as benzodiazepines, and this study suggests that phytoestrogens 
act in the same way that estrogen has been observed to do, in that it can increase the 
benzodiazepine binding sites on the GABA receptor (Zimmerberg and Farley, 1993).  
However, contrary to what is observed in the rats in this maze test, the activation of 
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GABA receptors also results in sedation and a decrease in locomotor behavior (Lephart et 
al., 2002).  It proposed that the anxiolytic effects were through activation of the GABA 
receptor, but two thirds of the other known effects of the GABA receptor were not 
observed.  It could therefore be hypothesized that rather through the actions of the GABA 
receptor, the phytoestrogens exert their anxiolytic effects through the increase production 
of OT, which has substantial evidence for reducing anxiety behaviors.  If the 
phytoestrogens mimic estrogen, it could result in the binding of these phytoestrogens to 
ERβ, which would increase the production of the OT peptide in the brain, resulting in the 
OT driven anxiolytic behavior, rather than the GABA receptor driven anxiolytic 
behavior.  While the study did not acknowledge this possibility, it stands as model for 
how future studies could be conducted to investigate the cause of the anxiolytic 
behaviors, adding in the procedure of measuring OT levels following consumption and 
testing in the maze. 
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DISCUSSION 
 
Brain Regions Affected (and corresponding behavioral implications) 
 As mentioned earlier, the amygdala plays a central role in OT related behaviors.  
It is clear that upon binding to OTR, the activity of the amygdala is decreased, and this 
results in many of the key behavioral changes seen in both rat and human studies where 
OT is administered.  If ingested isoflavones have the potential to increase the distribution 
of OTR, or OT that could bind to the OTR, on the amygdala, there would be an increased 
likelihood for the amygdala to be muted.  This would result in a decrease in social 
inhibition as well as anxiolytic effects for the individual.  The OT influenced amygdala 
also decreases the release of cortisol from the adrenal glands through inhibition of the 
hypothalamus, which as mentioned above, is linked to cortisol by the HPA axis. 
 The PFC is also affected by OT, especially in the fear and anxiety circuit.  In the 
human ICH study, the entire cortex had a high density of ERs, allowing for significant 
binding of phytoestrogens, and the study by Lund et al. (2001) recorded localization of 
phytoestrogens in the cortex of mice, suggesting the potential for a high binding 
frequency in humans, if the phytoestrogen distribution in the brain is similar across 
species.  Upon binding to the ERs, of which ERβ is in a higher concentration, the ERs 
would begin production of OT and OTR, most likely more OT due to more ERβ (Mitra et 
al., 2003, Gonzalez et al., 2007).  This OT then has the potential to either bind to the 
newly formed OTR in the PFC, or other regions of the brain, such as the nearby 
amygdala.  This binding of OT to the amygdala will decrease anxiety and social 
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inhibition, as mentioned above, but will also strengthen the top-down control of the PFC 
over the amygdala, allowing for rationalization of fearful stimuli (See Figure 6). 
The Boccia et al. study (2013) found that the cingulate cortex had a very concentrated 
amount of OTR, leading to the potential for OT and OTR formation in that area in the 
presence of phytoestrogens.  The cingulate cortex has been implicated in decision making 
in reward outcome scenarios, similar to the caudate nucleus in the trust base studies 
(Aharoni et al., 2013, Delgado et al., 2005).  It is possible that the cingulate cortex and 
the caudate nucleus work in tandem to exert some of the trust based OT driven behaviors. 
 The study by Yoshimura, Yamamoto, and Endo (2011) found the SON and PVN 
both experience significant vacuolation in the presence of phytoestrogens.  This is the 
strongest piece of evidence of the ability of ingested soy to induce an increase in the 
production of the OT peptide in the brain.  The SON and PVN are the main location in 
the brain where OT is synthesized and then released centrally.  Even if no other area of 
the brain was affected by phytoestrogens, the increased OT production from these two 
sites would allow for the OT concentration in the cerebrospinal fluid to increase, causing 
an increased percentage of OTR being bound in the brain, and therefore an increased 
frequency or intensity of OT driven behaviors. 
 Gonzalez et al., (2007) also located a high density of ERs on the hippocampus, an 
area of the brain associated with forming memories.  Through the binding of 
phytoestrogens to these ERs in the hippocampus has the potential to synthesize both OT 
and OTR, making the area sensitive to OT levels.  Indeed, it has been suggested that OT 
plays a role in social memory, specifically recalling particular faces when associated with 
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particular emotions, which can be attributed to the hippocampus (Rimmele et al., 2009).  
While this area of research is very new, it suggests yet another behavior, memory, could 
be influenced by the ingestion of soy. 
From the most recent study into OTR localization in the human brain using IHC, 
there was no localization of OTR on the NAcc, an area that has a high density in 
monogamous prairie voles, and plays a key role in both maternal behavior and the reward 
system, which was associated with pair bonding (Boccia et al., 2013).  As discussed 
above in relation to mothers who experienced synchronized mothering behavior, the 
NAcc experienced significant activity, linking it in with OT regulated behaviors 
somehow, but the exact mechanism is less clear.  It seems that this mechanism in humans 
may vary from how it works in rodents such as rats or voles, since it is believed that OT 
binds to the OTR located on the NAcc, directly increasing the behaviors that the NAcc is 
chiefly responsible for through increased activity.  Without OTR on the NAcc in humans, 
this mechanism found in voles is likely not possible in humans, and must be studied 
further in both a behavioral and IHC manner to determine OT’s role. 
Sex Differences and Premenopausal vs. Postmenopausal  
 A key factor that affects how the ingestion of soy could possibly result in 
particular OT driven behaviors is the preexisting, endogenous levels of estrogen in the 
individual.  As described previously, in high levels of endogenous estrogen, such as in 
premenopausal women, the isoflavones from the ingested soy are likely to act as an 
estrogen antagonist, resulting in a decrease in OT and OTR production, as well as a 
decrease in the OT driven behaviors.  This means that, if this hypothesis is valid, 
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maternal behavior would decrease in premenopausal women ingesting soy.  Based off of 
OT’s role in female’s sexual behaviors, premenopausal women may feel less relaxed 
after sexual intercourse and may have a harder time connecting with their sexual partner 
following the consumption of soy.  While social disorders tend to affect more males than 
females, a premenopausal woman would still experience a decrease in empathy, 
decreased ability to read social situations, and a decrease in reading facial cues and 
maintaining eye contact.  They would also experience a decreased level of trust in others, 
and would not experience the anxiolytic effects provided by OT.  In addition they may 
struggle to form significant bonds with their sexual partner, although the research on pair 
bonding is in its infancy for humans. 
 Men, who have low endogenous levels of estrogen will experience the opposite 
effects as premenopausal women, and will exhibit an increase in the OT driven 
behaviors.  For men, they would experience better sexual function, greater orgasm 
intensity and increased sexual satisfaction following intercourse.  They will have an 
easier time empathizing with others, be better at reading social situations, would increase 
their ability to read facial cues and increase eye contact with others.  They may feel the 
anxiolytic effects that OT brings and may also form stronger bonds with their sexual 
partner. While these behaviors may seem like they are all positive, there is a darker side 
to OT in men.  Obviously men do not exhibit maternal behaviors the same way that 
women do, but there is at least animal evidence that they are protective of their mate and 
young with the increased presence of OT.  In prairie voles, after pair bonding with a 
female and producing young with her, a male prairie vole with higher circulating levels 
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of OT will be much more aggressive towards outsiders when they approach his mate and 
young (Bales and Carter, 2003). 
 Postmenopausal women also have low levels of endogenous estrogen, and 
because of this it is hypothesized that behaviorally, they would experience increases in 
OT driven behaviors following ingestion of soy products.  This distinction between 
premenopausal and postmenopausal women is important, since the difference in how they 
could potentially experience the behavioral effects of OT brought on by soy is significant. 
It should be emphasized that the onset and duration of these behavioral changes is 
not known.  If the behaviors are a resultant of mainly the increased production of OT, 
then it may be a quick onset and a very short lasting behavioral change due to the short 
half-life of the OT peptide, but it the behaviors are the result of an increased transcription 
and expression of the OTR, then the onset may be a delayed onset, but a longer lasting 
behavioral change. 
Animal to Human Crossover 
While some behaviors have stronger evidence for OT’s role in modulating them 
within humans, others have thus far only been studied in animal models.  Trust, social 
cues, maternal behavior, anxiolytic effects, and for the most part, sexual behaviors, have 
the human studies to support the hypothesis that OT plays a significant role in these 
behaviors in humans.   It is therefore worth suggesting future studies to attempt to verify 
the significance of OT in the behavior of pair bonding, the behavior linked to OT that 
does not have as substantial human studies, and therefore cannot be strongly supported.  
As discussed above, there are varying ER and OTR distributions in humans compared to 
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the other animal models where ERs and OTRs has been mapped out.  Without strong 
support, these behaviors cannot be assumed to be altered via an OT based mechanism in 
the presence of a phytoestrogen rich diet. 
Future Studies 
One of the biggest gaps in the studies is the lack of substantial evidence for the 
effect of phytoestrogens on human brain structure.  For obvious ethical reasons, this will 
continue to provide a substantial barrier to drawing a conclusive link between soy 
consumption and altered brain OT and OTR levels and distribution.  However, future 
studies could be done to determine an observable change in behavior following a soy rich 
diet.  Looking at key behaviors such as level of trust, socialness, empathy and stress 
level, subjects could be put into several study groups to address key questions that this 
study has exposed.  The first order of division would be a group fed a soy rich diet, and a 
group fed a diet lacking in soy.  The content of isoflavones would be known and 
maintained, so as to best maintain consistency.  Within the soy rich and no soy diet 
groups, they would be further divided by gender, then, within the women, by 
premenopausal and postmenopausal.  This last point is very important, since the current 
data suggests the preexisting levels of endogenous estrogen will affect whether the 
isoflavones act as estrogenic or antiestrogenic in the body.  One would predict that in 
premenopausal women, isoflavones from soy would act antiestrogenically, thus resulting 
in a decrease in pro-OT behaviors, such as decreased trust, increased stress, decreased 
socialness and decreased maternal behavior.  Men and postmenopausal women on the 
other hand, would be predicted to have increased pro-OT behaviors, enhancing trust, 
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socialness, empathy, and decreasing stress. 
To further dissect the effects of soy consumption on OT induced behaviors, 
determining  the timetable for these behavioral changes would be helpful.  How long 
does it take for these behavioral changes to be observed?  How long do they last?   Are 
they dose dependent or is there a threshold, that once reached, results in a standard degree 
of behavioral change?  Is there a gender difference, or a premenopausal to 
postmenopausal difference, in how quickly the behavioral changes take place and how 
long they last? 
Purely observational changes in behavior, however, do not necessarily mean that 
changes in OT and OTR are causing it.  The isoflavones in the soy could cause these 
behavioral changes through a yet unknown mechanism.  To collect data that would 
strongly support the idea that soy consumption alters behavior through varied levels of 
OT and OTR, a more invasive, but effective study would be needed.  At various intervals 
after consumption of the designated diet, samples of cerebral spinal fluid would need to 
be taken from individuals to measure OT and the mRNA of OTR located within the 
brain.  This, however, is a painful procedure, would need to be done quickly and 
frequently due to OT’s known short half life of around 15 minutes in the blood, and 
estimated hour in the brain (Born et al., 2002).  So the likelihood of this being performed 
on humans is unlikely due to its uncomfortable and labor intensive nature.  
The study by Yoshimura, Yamamoto, and Endo (2011) only analyzed the 
morphological changes in the PVN and SON following isoflavone ingestion, excluding 
other areas of the brain that are essential to this paper.  Areas such as the amygdala, 
56 
prefrontal cortex, NAcc, and the caudate nucleus could have undergone OT neuron 
remodeling, size increases, and OT vacuolization.  To know how these areas, areas that 
have been implicated in key OT driven behaviors, are altered in the presence of 
isoflavones is essential to better understand dietary soy’s role in altering these behaviors.  
A repeat study with analysis of these brain areas would shed light on the question of how 
isoflavones affect them.  It would also be beneficial to see if similar morphological 
changes occur in adult mice, or if they only occur during a critical window in the 
developmental period of early postnatal mice.  Along that line, it would also be beneficial 
to have multiple groups of mice, fed isoflavones at varying times in their lives, and 
sacrificed at various points in their lives to compare morphological changes in OT 
neurons.  From this study, not only could a potential critical window be determined, but a 
timeline of how long the morphological changes lasted could be established.  Take for 
example one cohort of mice that have all been fed an isoflavone rich diet since birth, for 
maybe about a week.  Following this first week, they are all switched to an isoflavone 
free diet, and sacrificed in daily increments.  A few mice are sacrificed the last say of 
they isoflavone rich diet, then a few are the first day of an isoflavone free diet, and so on, 
until you have brain sections of mice that are incrementally further away from they 
isoflavone rich diet.  The density and morphology of the brain sections could be analyzed 
and compared, not only to the other mice in the isoflavone rich diet cohort, but a control 
cohort with an isoflavone free diet that is sacrificed in identical increments.  This would 
allow for observations of morphological changes over time, and if the isoflavones’ effects 
on the mouse brain are only transient, rather than permanent, the period of time that these 
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changes occur for could be determined.  There could be many studies done with a similar 
structure to look more closely at the extent and duration of phytoestrogen driven 
morphological changes on OT neurons. 
Another series of studies that must be utilized for more accurate cross species 
analysis is to utilize IHC staining technique, specifically with the monoclonal antibody 
2F8, instead of autoradiography, which has been used on the vast majority of animal 
studies mapping out the distribution and concentration of OTR in brain tissue.  Utilizing 
IHC will not only make the OTR mapping more accurate, since there will be a reduced 
likelihood of cross binding with vasopressin receptors, but it will also make comparing 
the staining done by Boccia et al., (2013) to these animal models more valid.  This will 
allow a side-by-side comparison of each brain area and its OTR distribution from the 
same staining technique.  Along those same lines, another 2f8 IHC staining could be done 
in the male human brain.  Sexual dimorphism in the human brain is a very real variable to 
consider, especially in relation to a hormone that plays such a key role in female centered 
activities such as birth and breast-feeding.  To better understand how alterations in OTR 
concentration would affect female and male behaviors, the exact brain areas with high 
OTR need to be known, since those areas will be directly altered by the ingestion of 
phytoestrogens, and the coinciding OTR concentration change will alter OT driven 
behaviors, according to the area of the brain affected. 
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Summary 
Drawing from other studies done on a wide range of topics, there is a strong 
argument for phytoestrogens influencing OT regulated behaviors in humans.  Contrary to 
the original hypothesis, studies seem to point to a decrease in these OT regulated 
activities for females with premenopausal levels of estrogen. Lining up with the original 
idea, it seems supported that males and postmenopausal women, due to the low level of 
endogenous estrogen do experience an increase in the OT regulated behaviors.  While 
significant human based research must still be done to draw conclusive support for this 
idea, the trends seem to suggest that the behavioral implications of soy ingestion may be 
more significant than previously believed.   
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